Summary
Aqueous solutions of peroxovanadium (pV) compounds are potent insulin-mimics in various types of cell. Since chemical instability is a problem with these agents, we studied the insulin-like action in human fat cells of a stable pV complex, bpV(pic). It enhanced 14C-U-glucose uptake in a dose-dependent manner by approximately twofold which was slightly less than the effect of insulin (approximately threefold). The pV complex did not alter cell-surface insulin binding and submaximal concentrations did not influence cellular sensitivity to insulin action on glucose uptake. The bpV(pic) inhibited the lipolytic effect of isoprenaline to the same extent as insulin; however, when the cGMP-inhibitable low-Km phosphodiesterase (cGI-PDE) was blocked with the specific inhibitor OPC 3911, the antilipolytic effect of insulin, but not that of bpV(pic), was completely prevented. Moreover, when lipolysis was stimulated by the non-hydrolysable cAMP analogue N6-monobutyryl cAMP, bpV(pic), in contrast to insulin, maintained an antilipolytic effect. These findings indicate that bpV(pic) exerts its antilipolytic effect not only through cGI-PDE activation, similar to the effect of insulin, but also by means of other mechanisms. The tyrosine kinase activity of insulin receptors from human placenta was not altered by the pV compound itself, whereas bpV(pic) clearly enhanced insulin-stimulated activity. In contrast, in situ tyrosine phosphorylation of the insulin receptor Β-subunit as well as that of several other proteins was clearly increased in cells which were treated with bpV(pic), whereas vanadate only amplified insulin-stimulated tyrosine phosphorylation. In conclusion, bpV(pic) exerts powerful insulin-like effects in human fat cells and may be a new and potentially useful agent in the management of insulin-resistant states.
Article PDF
Similar content being viewed by others
Abbreviations
- pV:
-
Peroxovanadium
- bpV(pic):
-
potassium bisperoxopicolinatooxovanadate
- cGI-PDE:
-
cGMP-inhibitable low-km phosphodiesterase
- EC50 :
-
half-maximal concentration
- PTP:
-
phosphotyrosine phosphatase
- sp act:
-
specific activity
- WGA:
-
wheat-germ agglutinin
References
Shechter Y (1990) Insulin-mimetic effects of vanadate: possible implications for future treatment of diabetes. Diabetes 39:1–5
Nechay BR (1984) Mechanisms of action of vanadium. Ann Rev Pharmacol 24: 501–524
Tolman EL, Barris E, Burns M, Pansini A, Partridge R (1979) Effects of vanadium on glucose metabolism in vivo. Life Sci 25:1159–1164
Shechter Y, Karlish SJD (1980) The insulin-mimetic effects of vanadate in isolated rat adipocytes. Nature (London) 284: 556–558
Mooney RA, Bordwell KL, Luhowskyj S, Casnellie JE (1989) The insulin-like effect of vanadate on lipolysis in rat adipocytes is not accompanied by an insulin-like effect on tyrosine phosphorylation. Endocrinology 124: 422–429
Tamura S, Brown TA, Wipple JH et al (1984) A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes. J Biol Chem. 259: 6650–6658
Heyliger CE, Tahiliant AG, McNeill JH (1985) Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 227: 1474–1476
Blondel O, Bailbe D, Portha B (1989) In vivo insulin resistance in streptozotocin-diabetic rats — evidence for reversal following oral vanadate treatment. Diabetologia 32: 185–190
Bernier M, Laird DM, Lane MD (1988) Effect of vanadate on the cellular accumulation of ppl5, an apparent product of insulin receptor tyrosine kinase action. J Biol Chem 263: 13626–13634
Swarup G, Speeg KV Jr, Cohen S, Garbers DL (1982) Phosphotyrosyl-protein phosphatase of TCRC-2cells. J Biol Chem 257: 7298–7301
Strout HV, Vicario P, Saperstein R, Slater EE (1989) The insulin-mimetic effect of vanadate is not correlated with insulin receptor tyrosine kinase activity nor phosphorylation in mouse diaphragm in vivo. Endocrinology 124: 1918–1924
Czech MP, Lawrence JC Jr, Lynn WS (1974) Hexose transport in isolated brown fat cells. J Biol Chem 249: 5421–5427
Muchmore DB, Little SA, deHaen C (1982) Counterregulatory control of intracellular hydrogen peroxide production by insulin and lipolytic hormones in isolated rat epididymal fat cells. A role of free fatty acids. Biochemistry 21: 3886–3892
Krieger-Brauer HI, Kather H (1992) Human fat cells possess a plasma membrane-bound H2O2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J Clin Invest 89: 1006–1013
Kadota S, Fantus IG, Deragon G, Guyda HJ, Hersh B, Posner BI (1987) Peroxide(s) of vanadium, a novel and potent insulin-mimetic agent which activates the insulin receptor kinase. Biochem Biophys Res Commun 147: 259–266
Kadota S, Fantus IG, Deragon G, Guyda HJ, Posner BI (1987) Stimulation of insulin-like growth factor II receptor binding and insulin receptor kinase activity in rat adipocytes. Effects of vanadate and H2O2. J Biol Chem 262: 8252–8256
Faure R, Baquiran G, Bergeron JJM, Posner BI (1992) The dephosphorylation of insulin and epidermal growth factor receptors. Role of endosome-associated phosphotyrosine phosphatase(s). J Biol Chem 267: 11215–11221
Posner BI, Faure R, Burgess JW et al. (1994) Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimicks. J Biol Chem 269: 4596–4604
Lönnroth P, Eriksson JW, Posner BI, Smith U (1993) Peroxovanadate but not vanadate exerts insulin-like effects in human adipocytes. Diabetologia 36: 113–116
Smith U, Sjöström L, Björntorp P (1972) Comparison of two methods for determining human adipose cell size. J Lipid Res 13: 822–824
Kashiwagi A, Verso MA, Andrews J, Vasques B, Reaven G, Foley JE (1983) In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus. J Clin Invest 72: 1246–1252
Bradley DC, Kaslow HR (1989) Radiometric assays for glycerol, glucose, and glycogen. Anal Biochem 180: 11–16
Harrison LC, Itin A (1980) Purification of the insulin receptor from human placenta by chromatography on immobilized wheat germ lectin and receptor antibody. J Biol Chem 255: 12066–12072
Zick Y, Kasuga M, Kahn CR, Roth J (1983) Characterization of insulin-mediated phosphorylation of the insulin receptor in a cell-free system. J Biol Chem 258: 75–80
Eriksson JW, Lönnroth P, Smith U (1992) Vanadate increases cell surface insulin binding and improves insulin sensitivity in both normal and insulin-resistant rat adipocytes. Diabetologia 35: 510–516
Degerman E, Belfrage P (1987) Purification of the putative hormone-sensitive cyclic AMP phosphodiesterase from rat adipose tissue using a derivative of cilostamide as a novel affinity ligand. J Biol Chem 262: 5797–5807
Manganiello V, Degerman E, Elks M (1988) Selective inhibitors of specific phosphodiesterases in intact adipocytes. Methods Enzymol 154: 504–520
Beebe SJ, Holloway R, Rannels SR, Corbin JD (1984) Two classes of cAMP analogs which are selective for the two different cAMP-binding sites of type-II protein kinase demonstrate synergism when added together to intact adipocytes. J Biol Chem 259: 3539–3547
Degerman E, Smith CJ, Tornqvist H, Vasta V, Belfrage P, Manganellio VC (1990) Evidence that insulin and isoprenaline activate the cGMP inhibited low-Km cAMPphosphodiesterase in rat fat cells by phosphorylation. Proc Natl Acad Sci USA 87: 533–537
Shibata H, Robinson FW, Soderling TR, Kono T (1991) Effects of okadaic acid on insulin-sensitive cAMP phosphodiesterase in rat adipocytes. J Biol Chem 266: 17948–17953
Fantus IG, Ahmad F, Deragon G (1990) Vanadate augments insulin binding and prolongs insulin action in rat adipocytes. Endocrinology 127: 2716–2725
Shisheva A, Shechter Y (1993) Role of cytosolic tyrosine kinase in mediating insulin-like actions of vanadate in rat adipocytes. J Biol Chem 268: 6463–6469
Elberg G, Li J, Shechter Y (1994) Vanadium activates or inhibits receptor and non-receptor protein tyrosine kinases in cell-free experiments depending on its oxidation state. Possible role of endogenous vanadium in controlling cellular protein tyrosine kinase activity. J Biol Chem 269: 9521–9527
Lönnroth P, Smith U (1986) The antilipolytic effect of insulin in human adipocytes requires activation of the phosphodiesterase. Biochem Biophys Res Commun 141: 1157–1161
Ueki H, Okuhama R, Sera M, Inoue T, Tominaga N, Morita T (1992) Stimulatory effect of vanadate on 3 ′, 5 ′-cyclic guanosine monophosphate-inhibited low Michaelis-Menten constant 3 ′, 5 ′-cyclic adenosine monophosphate phosphodiesterase activity in isolated rat fat pads. Endocrinology 131: 441–446
Maj JM, de Haen C (1979) Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cells. J Biol Chem 254: 2214–2220
Fantus IG, Kadota S, Deragon G, Foster B, Posner BI (1989) Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase. Biochemistry 28: 8864–8871
Shisheva A, Ikonomov O, Shechter Y (1994) The protein tyrosine phosphatase inhibitor, pervanadate, is a powerful antidiabetic agent in streptozotocin-treated diabetic rats. Endocrinology 134: 507–510
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eriksson, J.W., Lönnroth, P., Posner, B.I. et al. A stable peroxovanadium compound with insulin-like action in human fat cells. Diabetologia 39, 235–242 (1996). https://doi.org/10.1007/BF00403968
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00403968